麻豆原创

Search

Did you mean
non-alcohol drinks
Your search for "non-alcoholic drinks" gave back 6 results.

Asia Pacific Biosimilars 麻豆原创 2020-2030 by Product Type, Indication, Manufacturing (Contract, Inhouse), End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
Asia Pacific
November 2021
Price: USD 2,700.00

Europe Biosimilars 麻豆原创 2020-2030 by Product Type, Indication, Manufacturing (Contract, Inhouse), End User, and Country: Trend Forecast and Growth Opportunity

Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
Europe
November 2021
Price: USD 2,700.00

North America Biosimilars 麻豆原创 2020-2030 by Product Type, Indication, Manufacturing (Contract, Inhouse), End User, and Country: Trend Forecast and Growth Opportunity

North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
North America
November 2021
Price: USD 2,700.00

Global Biosimilars 麻豆原创 2020-2030 by Product Type, Indication, Manufacturing (Contract, Inhouse), End User, and Region: Trend Forecast and Growth Opportunity

Global biosimilars market will reach $113.25 billion by 2030, growing by 25.7% annually over 2020-2030 driven by the affordability of biosimilar-...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
Global
November 2021
Price: USD 3,200.00

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research鈥檚 latest report, 鈥淚nnovation...
颁补迟补濒辞驳:听
Research & Development (Pharma & Healthcare)
CBR Pharma Insights
Global
May 2017
Price: USD 2,995.00

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
颁补迟补濒辞驳:听
Treatments
CBR Pharma Insights
Global
January 2018
Price: USD 2,995.00

Contact Us for Custom 麻豆原创 Research Solutions

听

Custom 麻豆原创 Research Reports

Clients Who Trust Us

麻豆原创 Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected